×
Waters Revenue 2010-2024 | WAT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Waters revenue for the twelve months ending June 30, 2024 was
$2.877B
, a
3.87% decline
year-over-year.
Waters annual revenue for 2023 was
$2.956B
, a
0.52% decline
from 2022.
Waters annual revenue for 2022 was
$2.972B
, a
6.68% increase
from 2021.
Waters annual revenue for 2021 was
$2.786B
, a
17.78% increase
from 2020.
View More
Waters Revenue 2010-2024 | WAT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Waters annual revenue for 2023 was
$2.956B
, a
0.52% decline
from 2022.
Waters annual revenue for 2022 was
$2.972B
, a
6.68% increase
from 2021.
Waters annual revenue for 2021 was
$2.786B
, a
17.78% increase
from 2020.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$214.1B
Intuitive Surgical (ISRG)
$183.6B
Alcon (ALC)
$45.1B
IQVIA Holdings (IQV)
$40.2B
Edwards Lifesciences (EW)
$39.6B
IDEXX Laboratories (IDXX)
$34.7B
DexCom (DXCM)
$26.8B
STERIS (STE)
$22.4B
SONOVA HOLDING (SONVY)
$21.9B
Hologic (HOLX)
$18.7B
Fresenius Medical Care AG KGaA (FMS)
$12.4B
Sysmex ADR (SSMXY)
$11.9B
Globus Medical (GMED)
$11.2B
Teleflex (TFX)
$9.4B
Penumbra (PEN)
$9B
Masimo (MASI)
$8.9B
Glaukos (GKOS)
$7.8B
PROCEPT BioRobotics (PRCT)
$5.1B
Integer Holdings (ITGR)
$4.5B
Inari Medical (NARI)
$3.1B
TransMedics (TMDX)
$2.9B
LivaNova (LIVN)
$2.8B
Veracyte (VCYT)
$2.8B
Nihon Kohden (NHNKY)
$2.5B
Tandem Diabetes Care (TNDM)
$2.2B
Elekta AB (EKTAY)
$2.2B
Integra LifeSciences Holdings (IART)
$2.1B
RxSight (RXST)
$2B
Alphatec Holdings (ATEC)
$1.3B
Artivion (AORT)
$1.2B